Sign in

CIK 0001287098

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

MAXCYTE, INC.

Sign in to watch
Ticker
MXCT
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
522210438
Phone
+1 301-517-5556
Business address
9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
Former names
MAXCYTE INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale EVP, Global Sales & Marketing sold 29,133 shares at an average $5.72 ($166,517)
  8. 4 Open-market sale President and CEO sold 30,000 shares at an average $5.72 ($171,553)
  9. 4 Open-market sale President and CEO sold 30,000 shares at an average $5.08 ($152,430)
  10. 4 Open-market sale EVP, Global Sales & Marketing sold 29,133 shares at an average $5.08 ($148,051)
  11. 4 Open-market sale EVP, Global Sales & Marketing sold 29,133 shares at an average $5.81 ($169,303)
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale EVP, Global Sales & Marketing sold 29,133 shares at an average $6.92 ($201,670)
  15. 4 Open-market sale EVP, Global Sales & Marketing sold 29,133 shares at an average $6.46 ($188,165)
  16. 4 Open-market sale 10% owner sold 735,786 shares at $6.15 ($4,525,084)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 9 · 164 filings